Proof of Concept (POC) in Patients With Ischaemic Stroke


Phase 2 Results

Summary of Purpose

Study MAG104615, a Proof of Concept Study for GSK249320 versus placebo in Stroke Patients. Trial Stopped: This study was terminated for futility.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 October 2017.

18 May 2013 14 Feb 2013 28 Jul 2014 28 Jul 2014 1 Sep 2017 9 Jun 2017
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment